PA
ARHS icon

PharVision Advisers’s Arhaus ARHS Stock Holding History

PharVision Advisers’s Portfolio ARHS Stock Details ARHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Sell
10,178
-9,181
-47% -$83.4K 0.7% 75
2025
Q4 		$217K Sell
19,359
-11,200
-37% -$116K 0.11% 494
2025
Q3 		$325K Buy
+30,559
New +$322K 0.18% 183

Other funds holding ARHS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

PharVision Advisers's ARHS Position: Q1 2026 in Review

PharVision Advisers reduced its Arhaus (ARHS) stake by 47% in Q1 2026, selling an estimated $83.4K and leaving 10,178 shares worth $69K. The position accounts for 0.7% of the portfolio, ranked #75.

PharVision Advisers first reported a position in ARHS in Q3 2025 and has held it in 3 quarters since. The position peaked at $325K in Q3 2025. 177 funds tracked by Wall St. Rank hold ARHS as of Q1 2026.

  • PharVision Advisers held 10,178 shares of Arhaus worth $69K as of Q1 2026.
  • PharVision Advisers sold 9,181 Arhaus shares in Q1 2026, an estimated $83.4K.
  • Arhaus made up 0.7% of PharVision Advisers's portfolio in Q1 2026, its #75 holding.
  • PharVision Advisers first reported a position in Arhaus in Q3 2025 and has held it in 3 quarters since.
  • PharVision Advisers's Arhaus position peaked at $325K in Q3 2025.
  • 177 funds tracked by Wall St. Rank held Arhaus as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.